Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2017-07-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by a regulatory authority (Jilin Province Food and Drug Administration). It details product registration numbers, validity periods, and clinical uses. The document includes a statement from the company's board ensuring the accuracy of the disclosure and discusses the potential impact on the company's business and market competitiveness. The document is short (1196 characters) and is an announcement of a regulatory approval event rather than a financial report, management change, or other specific filing types. It does not contain financial data, voting results, or executive changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2017-07-28 Chinese
2017年半年度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a '2017 半年度业绩预告' which translates to '2017 Half-Year Performance Forecast'. It provides estimated financial results for the period January 1, 2017 to June 30, 2017, including expected net profit growth percentages and reasons for performance changes. It explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the company's 2017 half-year report. The document is short (883 characters) and serves as a preliminary earnings forecast rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. H1 2017
2017-07-11 Chinese
关于使用闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using idle funds to purchase financial products. It details the types of financial products bought, investment amounts, expected returns, risk disclosures, and risk control measures. The document is relatively short (3223 characters) and focuses on a specific financing activity rather than comprehensive financial results or management discussion. It does not contain full financial statements or detailed financial analysis. It is not an annual or interim report, nor an earnings release. It is not a regulatory certification or a report publication announcement. The content fits best with an update on company financing activities, specifically the use of idle funds to purchase financial products. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2017-06-27 Chinese
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by a regulatory authority (Jilin Province Food and Drug Administration). It details the registration numbers, validity periods, product descriptions, and the significance of these certifications for the company's product portfolio and market competitiveness. The document does not contain financial data, financial results, or detailed financial analysis. It is not a report like an Annual Report, Interim Report, or Earnings Release. It is also not a regulatory filing about shareholding, management changes, or legal matters. The document is an official announcement about regulatory approval of products, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2017-06-12 Chinese
关于完成公司名称变更的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement regarding the completion of a company name change and related amendments to the company charter. It includes details about the new company name, registration information, and reasons for the change. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes. The document is a formal regulatory announcement about corporate information changes, specifically a name change, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2017-05-12 Chinese
2016年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2016 annual equity distribution (dividend) plan approved at the 2016 Annual General Meeting. It details the dividend amount per share, the record date, the ex-dividend date, the dividend payment method, and related tax information. It does not contain financial statements or detailed financial performance data but focuses on the dividend distribution specifics. This matches the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and details for shareholders. The document length is short (1642 characters), and it is not a report publication announcement or a regulatory filing. Therefore, the correct classification is DIV with high confidence.
2017-05-04 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.